Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 18;11(2):339.
doi: 10.3390/diagnostics11020339.

The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization

Valentina Angerilli  1 , Francesca Galuppini  1 , Fabio Pagni  2 , Nicola Fusco  3   4 , Umberto Malapelle  5 , Matteo Fassan  1
Affiliations
Review

The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization

Valentina Angerilli et al. Diagnostics (Basel). .

Abstract

Current pathology practice is being shaped by the increasing complexity of modern medicine, in particular of precision oncology, and major technological advances. In the "next-generation technologies era", the pathologist has become the person responsible for the integration and interpretation of morphologic and molecular information and for the delivery of critical answers to diagnostic, prognostic and predictive queries, acquiring a prominent position in the molecular tumor boards.

Keywords: molecular pathology; next generation technologies; oncology; predictive biomarkers.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare related to the presented work. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Schematic representation of next-generation pathologist area of expertise, from tissue management and analysis (A), including cytological samples and body fluids (B,C), to fully morpho-molecular characterization (D–F) of patients. (G–J): schematic representation of integrative data analysis among drug dose–response (G), cell line expression profile (H) and next-generation results on DNA (I) and RNA (J). Credit by Biorender.
See this image and copyright information in PMC

References

    1. Watson J.D., Crick F.H.C. Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid. Nat. Cell Biol. 1974;248:765. doi: 10.1038/248765a0. - DOI - PubMed
    1. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer Genome Landscapes. Science. 2013;339:1546–1558. doi: 10.1126/science.1235122. - DOI - PMC - PubMed
    1. Harris T.J.R., McCormick F. The molecular pathology of cancer. Nat. Rev. Clin. Oncol. 2010;7:251–265. doi: 10.1038/nrclinonc.2010.41. - DOI - PubMed
    1. Lindeman N.I., Cagle P.T., Aisner D.L., Arcila M.E., Beasley M.B., Bernicker E.H., Colasacco C., Dacic S., Hirsch F.R., Kerr K., et al. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. J. Mol. Diagn. 2018;20:129–159. doi: 10.1016/j.jmoldx.2017.11.004. - DOI - PubMed
    1. Sepulveda A.R., Hamilton S.R., Allegra C.J., Grody W., Cushman-Vokoun A.M., Funkhouser W.K., Kopetz S.E., Lieu C., Lindor N.M., Minsky B.D., et al. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J. Clin. Oncol. 2017;35:1453–1486. doi: 10.1200/JCO.2016.71.9807. - DOI - PubMed